← FDA Drug Approvals (Drugs@FDA)

IVERMECTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EPIC PHARMA LLC · Approved 2025-09-09

Drug application

FDA Application #
ANDA218805
Application type
Abbreviated New Drug Application (Generic)
Brand name
IVERMECTIN
Generic name
Ivermectin
Active ingredients
IVERMECTIN
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
EPIC PHARMA LLC
First approval
2025-09-09

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown